Table 3.
Assessment by patients | Assessment by doctors | |||
---|---|---|---|---|
Unadjusted | Adjusted | Unadjusted | Adjusted | |
OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | |
Country/region of origin | ||||
Norway | 1 | 1 | 1 | 1 |
Nordic countries | 0.66 (0.45–0.96)* | 0.99 (0.60–1.64) | 0.64 (0.42–0.97)* | 0.81 (0.50–1.32) |
Western Europe/North America and Oceania | 1.18 (0.62–2.25) | 1.16 (0.55–2.42) | 0.92 (0.47–1.81) | 1.06 (0.53–2.12) |
Eastern Europe | 3.18 (1.76–5.74)** | 3.04 (1.60–5.78)** | 0.76 (0.49–1.16) | 0.81 (0.51–1.30) |
Asia with Turkey | 3.68 (2.34–5.77)** | 4.08 (2.43–6.84)** | 1.04 (0.77–1.41) | 1.01 (0.73–1.39) |
Africa | 4.25 (2.42–7.47)** | 8.47 (3.87–18.5)** | 0.49 (0.33–0.72)** | 0.64 (0.43–0.96)* |
Latin America | 1.70 (0.64–4.55) | 1.82 (0.59–5.55) | 1.21 (0.53–2.80) | 1.09 (0.45–2.61) |
Gender | ||||
Female | 1 | 1 | ||
Male | 1.14 (0.87–1.49) | 0.95 (0.76–1.19) | ||
Age (years) | ||||
0–19 | 1 | 1 | ||
20–39 | 0.91 (0.67–1.24) | 1.28 (0.97–1.68) | ||
40–59 | 2.28 (1.42–3.66)** | 2.05 (1.46–2.88)** | ||
≥60 | 2.73 (1.50–4.97)** | 2.46 (1.61–3.76)** | ||
Self-reported RGP status | ||||
Registered | 1 | 1 | ||
Not registered | 0.68 (0.43–1.07) | 0.86 (0.57–1.29) | ||
Time of consultation | ||||
08:00 a.m. – 03:59 p.m. | 1 | 1 | ||
04:00 p.m. – 10:59 p.m. | 1.03 (0.79–1.35) | 1.16 (0.92–1.46) | ||
11:00 p.m. – 07:59 a.m. | 2.91 (1.61–5.27)** | 2.35 (1.61–3.43)** |
RGP regular general practitioner
Norwegians used as the reference group. OR (odds ratio)
*Significant result at the p < 0.05 level, ** p < 0.001